Table I.
Patient demographic and risk factor profiles*
| Group |
||||
|---|---|---|---|---|
| Characteristic | Overall | Statin | Control | P |
| Limbs treated | 189 | 94 | 95 | |
| Men/women | 101/71 | 54/34 | 47/37 | .47 |
| Age (y) | 69 ± 10 | 67 ± 10 | 70 ± 11 | <.04 |
| Diabetes | 104 | 58 | 46 | .14 |
| Smoking | 35 | 17 | 18 | .73 |
| Hypertension | 114 | 54 | 60 | .16 |
| Coronary artery disease | 94 | 59 | 35 | <.01 |
| Prior coronary artery bypass grafting | 42 | 28 | 14 | <.02 |
| Congestive heart failure | 26 | 13 | 13 | .90 |
| Arrythmia/atrial fibrillation | 24 | 10 | 14 | .27 |
| Cerebrovascular disease | 27 | 13 | 14 | .73 |
| Chronic pulmonary disease | 16 | 8 | 8 | .92 |
| Chronic renal disease | 49 | 20 | 29 | .09 |
| Hemodialysis-dependent | 31 | 11 | 20 | .05 |
| Perioperative total cholesterol (mg/dL) | 170 ± 60 (n = 80) | 174 ± 66 (n = 38) | 168 ± 54 (n = 42) | .67 |
| Statin type (n = 88) | ||||
| Atorvastatin | 28 (30%) | |||
| Cerivastatin | 1 (1%) | |||
| Lovastatin | 3 (3%) | |||
| Pravastatin | 2 (2%) | |||
| Simvastain | 60 (64%) | |||
*
Data shown as either coded raw data (n) or summary data (mean ± SD).